Saguaro Biosciences has successfully raised $3,000,000 in funding to support its innovative cell culture products that aim to revolutionize the drug discovery process. Among its groundbreaking offerings is ChromaLive, a cutting-edge non-toxic dye designed to unlock unique phenotypic signatures from microscopy images of cells. This transformative technology enables the quantification of disease-relevant phenotypes such as cellular apoptosis, stress, autophagy, and more. With its easy add-and-mix feature, ChromaLive is poised to streamline automation workflows, live cell painting, 3D cultures, lengthy kinetic imaging, and the study of patient-derived cells. The company's commitment to advancing human health through disruptive technologies underscores its dedication to accelerating the development of new therapies and making them accessible to patients worldwide.









